These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29396103)

  • 1. Antihypertensive therapy in nondiabetic chronic kidney disease: a review and update.
    Der Mesropian PJ; Shaikh G; Cordero Torres E; Bilal A; Mathew RO
    J Am Soc Hypertens; 2018 Mar; 12(3):154-181. PubMed ID: 29396103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What should be the goal blood pressure in nondiabetic chronic kidney disease?
    Schneider MP; Hilgers KF
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):180-5. PubMed ID: 24401787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in Chronic Kidney Disease: Novel Insights.
    Duni A; Dounousi E; Pavlakou P; Eleftheriadis T; Liakopoulos V
    Curr Hypertens Rev; 2020; 16(1):45-54. PubMed ID: 30987570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatment and renal protection: Is there a J-curve relationship?
    Viazzi F; Leoncini G; Grassi G; Pontremoli R
    J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1560-1574. PubMed ID: 30267461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypertension in patients with nondiabetic chronic kidney disease.
    Ruzicka M; Burns KD; Culleton B; Tobe SW;
    Can J Cardiol; 2007 May; 23(7):595-601. PubMed ID: 17534470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of systemic hypertension in the progression of nondiabetic renal disease.
    Marcantoni C; Jafar TH; Oldrizzi L; Levey AS; Maschio G
    Kidney Int Suppl; 2000 Apr; 75():S44-8. PubMed ID: 10828761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of blood pressure control in chronic kidney disease.
    Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.
    Locatelli F; Del Vecchio L; Andrulli S; Colzani S
    Kidney Int Suppl; 2002 Dec; (82):S53-60. PubMed ID: 12410856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
    Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in chronic kidney disease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties.
    Kovesdy CP
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii219-ii223. PubMed ID: 28201651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.
    Jafar TH; Stark PC; Schmid CH; Landa M; Maschio G; de Jong PE; de Zeeuw D; Shahinfar S; Toto R; Levey AS;
    Ann Intern Med; 2003 Aug; 139(4):244-52. PubMed ID: 12965979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Hypertension in Chronic Kidney Disease.
    Kalaitzidis RG; Elisaf MS
    Curr Hypertens Rep; 2018 Jun; 20(8):64. PubMed ID: 29892833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension Management in Transition: From CKD to ESRD.
    Valika A; Peixoto AJ
    Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guiding lights for antihypertensive treatment in patients with nondiabetic chronic renal disease: proteinuria and blood pressure levels?
    Mulrow CD; Townsend RR
    Ann Intern Med; 2003 Aug; 139(4):296-8. PubMed ID: 12965986
    [No Abstract]   [Full Text] [Related]  

  • 20. Renoprotective effects of antihypertensive drugs.
    Preston RA
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):19S-32S. PubMed ID: 10077416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.